These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Mechanism and application of metformin in kidney diseases: An update. Song A; Zhang C; Meng X Biomed Pharmacother; 2021 Jun; 138():111454. PubMed ID: 33714781 [TBL] [Abstract][Full Text] [Related]
26. Limitations of metformin use in patients with kidney disease: are they warranted? Vasisht KP; Chen SC; Peng Y; Bakris GL Diabetes Obes Metab; 2010 Dec; 12(12):1079-83. PubMed ID: 20977579 [TBL] [Abstract][Full Text] [Related]
35. Metformin OK in CKD? Drug Ther Bull; 2014 Apr; 52(4):37. PubMed ID: 24698854 [No Abstract] [Full Text] [Related]
36. Metformin-associated lactic acidosis in a peritoneal dialysis patient. Almaleki N; Ashraf M; Hussein MM; Mohiuddin SA Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):325-8. PubMed ID: 25758883 [TBL] [Abstract][Full Text] [Related]
37. Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study. Kamber N; Davis WA; Bruce DG; Davis TM Med J Aust; 2008 Apr; 188(8):446-9. PubMed ID: 18429709 [TBL] [Abstract][Full Text] [Related]
38. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Salpeter S; Greyber E; Pasternak G; Salpeter E Cochrane Database Syst Rev; 2003; (2):CD002967. PubMed ID: 12804446 [TBL] [Abstract][Full Text] [Related]
39. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Salpeter S; Greyber E; Pasternak G; Salpeter E Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461 [TBL] [Abstract][Full Text] [Related]
40. Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease. Rhee JJ; Han J; Montez-Rath ME; Kim SH; Cullen MR; Stafford RS; Winkelmayer WC; Chertow GM J Diabetes Complications; 2019 Nov; 33(11):107423. PubMed ID: 31537413 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]